微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 41.01% | 0.69% | -5.11% | 97/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 43.22% | 6.59% | -0.79% | 93/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 43.56% | 13.56% | 9.35% | 90/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 39.84% | 11.89% | -2.2% | 106/160 | 51.38% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 40.73% | 16.9% | 0.46% | 104/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 40.55% | 16.17% | 5.7% | 104/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 38.36% | 2% | 7.74% | 105/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 35.6% | -11.2% | 2.18% | 113/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 34.84% | 2% | -0.18% | 107/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 34.9% | -18.3% | -12.95% | 111/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 40.09% | -11.76% | -6.15% | 105/160 | 55.07% | 迈威生物 | 98.57% | 行业排名> |
| 2021-06-30 | 42.72% | 2% | -5.98% | 93/160 | 47.45% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | 45.44% | 11.97% | 11.97% | 95/160 | -143.08% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 40.58% | 72.54% | 72.54% | 100/160 | -1204.25% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 23.52% | 2% | 2% | 126/160 | -205.91% | 艾力斯 | 99.4% | 行业排名> |